
|Articles|May 10, 2004
FDA approves thermodilatation system for treatment of BPH
Celsion Corp. has received FDA approval to market the Prolieve Thermodilatationsystem for the treatment of BPH symptoms. Boston Scientific will distributeand co-market the treatment.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










